99 related articles for article (PubMed ID: 8861023)
1. TIMP-2 mediates cell surface binding of MMP-2.
Corcoran ML; Emmert-Buck MR; McClanahan JL; Pelina-Parker M; Stetler-Stevenson WG
Adv Exp Med Biol; 1996; 389():295-304. PubMed ID: 8861023
[TBL] [Abstract][Full Text] [Related]
2. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
4. Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex.
Emmert-Buck MR; Emonard HP; Corcoran ML; Krutzsch HC; Foidart JM; Stetler-Stevenson WG
FEBS Lett; 1995 May; 364(1):28-32. PubMed ID: 7750537
[TBL] [Abstract][Full Text] [Related]
5. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
[TBL] [Abstract][Full Text] [Related]
9. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
10. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
11. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.
Deryugina EI; Luo GX; Reisfeld RA; Bourdon MA; Strongin A
Anticancer Res; 1997; 17(5A):3201-10. PubMed ID: 9413149
[TBL] [Abstract][Full Text] [Related]
13. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
[TBL] [Abstract][Full Text] [Related]
14. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
Azzam HS; Arand G; Lippman ME; Thompson EW
J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
[TBL] [Abstract][Full Text] [Related]
15. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
Kikkawa F
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
[TBL] [Abstract][Full Text] [Related]
16. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
17. Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model.
Atkinson SJ; Patterson ML; Butler MJ; Murphy G
FEBS Lett; 2001 Mar; 491(3):222-6. PubMed ID: 11240131
[TBL] [Abstract][Full Text] [Related]
18. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
[TBL] [Abstract][Full Text] [Related]
19. Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism.
Lafleur MA; Tester AM; Thompson EW
FEBS Lett; 2003 Oct; 553(3):457-63. PubMed ID: 14572669
[TBL] [Abstract][Full Text] [Related]
20. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Kawano N; Osawa H; Ito T; Nagashima Y; Hirahara F; Inayama Y; Nakatani Y; Kimura S; Kitajima H; Koshikawa N; Miyazaki K; Kitamura H
Hum Pathol; 1997 May; 28(5):613-22. PubMed ID: 9158711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
